22 results
8-K
EX-99.1
LIANY
LianBio
14 Aug 23
LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
Officer to oversee the continued growth of the company’s commercial capabilities. He will continue to also serve as the company’s China General Manager
8-K
EX-99.1
LIANY
LianBio
11 May 23
LianBio Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
Commercial Officer to oversee the continued growth of the company’s commercial capabilities in preparation for the anticipated mavacamten commercial
S-3
EX-25.1
LIANY
LianBio
10 Nov 22
Shelf registration
5:26pm
as may be duly designated by the Trust Management Committee shall oversee the processes related to fiduciary activities to assure conformity
10-K
2021 FY
EX-10.12
LIANY
LianBio
31 Mar 22
Annual report
8:55am
the Territory.
a)The second sentence of Section 3.6 is hereby amended and replaced in its entirety as follows:
Company will oversee, monitor
10-K
rdwve kos
31 Mar 22
Annual report
8:55am
S-1
EX-10.1
m6lc79tkkxx4p62djm9o
1 Oct 21
IPO registration
4:52pm
S-1
EX-10.5
pnygmv5
1 Oct 21
IPO registration
4:52pm
S-1
EX-10.14
3y3i4gpyv5wr1uctg uk
1 Oct 21
IPO registration
4:52pm
S-1
EX-10.12
uip1r7fwm2m5xl8h
1 Oct 21
IPO registration
4:52pm
S-1
EX-10.16
s81dlm wr3c20d
1 Oct 21
IPO registration
4:52pm
S-1
EX-10.15
u0xl09zo0ccjava4jws
1 Oct 21
IPO registration
4:52pm
S-1
EX-10.8
12md3f
1 Oct 21
IPO registration
4:52pm
DRS/A
1fi8wvd
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
EX-10.14
ny32f2bl7f7j feppcer
28 Jun 21
Draft registration statement
12:00am
DRS
EX-10.16
wdofilk8qx
28 Jun 21
Draft registration statement
12:00am
DRS
EX-10.1
kfzpjvjmffyochh
28 Jun 21
Draft registration statement
12:00am
DRS
EX-10.12
93ks746nb9
28 Jun 21
Draft registration statement
12:00am
DRS
EX-10.15
6nnxbez7q y3io4
28 Jun 21
Draft registration statement
12:00am
DRS
EX-10.8
6phpd8f3r
28 Jun 21
Draft registration statement
12:00am